Frequency Therapeutics Completes Enrollment Of Phase 2b Study Of FX-322 For The Treatment Of Sensorineural Hearing Loss
Frequency Therapeutics, Inc. (NASDAQ:FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person's innate potential to restore function, today announced that it has
atai Life Sciences Announces Initial Results For Phase 1 Trial Of KUR-101; Says ‘Initial results showed that single ascending oral dosing of KUR-101 produces dose-dependent analgesia (pain relief) with effects on respiration comparable to that of place…
– Initial results showed that single ascending oral dosing of KUR-101 produces dose-dependent analgesia (pain relief) with effects on respiration comparable to that of placebo.
– Topline
SunPower And GM Announce Collaboration To Develop New Home Energy System That Will Enable GM EVs To Provide Backup Energy To A Home; SunPower Named Preferred EV Charger Installation Provider And Exclusive Solar Provider
RICHMOND, Calif., Oct. 12, 2022 /PRNewswire/ -- Today, SunPower Corp. (NASDAQ:SPWR), a leading residential solar technology and energy services provider, and General Motors (NYSE:GM) announced a collaboration
Tiziana Life Sciences Plans To Submit IND For Phase 1 Trial Of Intranasal Foralumab In Alzheimer’s Disease Patients
Tiziana Life Sciences Ltd. (NASDAQ: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announcedTiziana Life Sciences Ltd.